Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
CA 2386985 A1 · Owner: Hill, David J. · Inventors: Remacle, Claude; Reusens, Brigitte; Hill, David J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a composition comprising an amino acid like structure carrying a sulfur moiety and a biologically acceptable carrier. The amino acid like structure carrying a sulfur moiety may be taurine L-cysteine, L-, methionine, or a combination of these. The composition may be used for inhibition of islet dysfunction or for inhibition of an autoimmune disorder. Conditions of islet dysfunction include insulitis Type 1 diabetes (IDDM), Type 2 diabetes (NIDDM) mature onset diabetes of the young (MODY) and , gestational diabetes. Autoimmune disorders inhibited by the composition include insulinitis, Type 1 diabetes, rheumatoid arthritis thyroiditis and , pancreatitis. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 11, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 11, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 11, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.